{
     "PMID": "11488404",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20010823",
     "LR": "20161124",
     "IS": "0024-3205 (Print) 0024-3205 (Linking)",
     "VI": "69",
     "IP": "8",
     "DP": "2001 Jul 13",
     "TI": "Carbetapentane attenuates kainate-induced seizures via sigma-1 receptor modulation.",
     "PG": "915-22",
     "AB": "We examined the effects of a non-opioid antitussive, carbetapentane (CB) on kainic acid (KA)-induced neurotoxicity in rats. KA administration (10 mg/kg, i.p.) produced robust behavioral convulsions lasting 4 to 5 h. CB (12.5 and 25 mg/kg. i.p.) pretreatment consistently and in a dose-dependent manner reduced the KA-induced seizures, mortality, and marked loss of cells in regions CA1 and CA3 of the hippocampus. Consistently, CB pretreatment also significantly attenuated the KA-induced increase in Fos-related antigen immunoreactivity in the hippocampus. In contrast, pretreatment with the sigma-1 receptor antagonist BD1047 (1 and 2 mg/kg, i.p.) blocked, in a dose-related manner, the neuroprotection afforded by CB. These results suggest that CB provides neuroprotection against KA insult via sigma-1 receptor modulation.",
     "FAU": [
          "Kim, H C",
          "Jhoo, W K",
          "Kim, W K",
          "Shin, E J",
          "Cheon, M A",
          "Shin, C Y",
          "Ko, K H"
     ],
     "AU": [
          "Kim HC",
          "Jhoo WK",
          "Kim WK",
          "Shin EJ",
          "Cheon MA",
          "Shin CY",
          "Ko KH"
     ],
     "AD": "Department of Pharmacy, College of Pharmacy, Korea Institute of Drug Abuse, Kangwon National University, Chunchon. kimhc@cc.kangwon.ac.kr",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Life Sci",
     "JT": "Life sciences",
     "JID": "0375521",
     "RN": [
          "0 (Benzoxazines)",
          "0 (Cyclopentanes)",
          "0 (Oxazines)",
          "0 (Receptors, sigma)",
          "0 (sigma-1 receptor)",
          "2AB49C465R (cresyl violet)",
          "32C726X12W (carbetapentane)",
          "SIV03811UC (Kainic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Benzoxazines",
          "Brain/drug effects/metabolism",
          "Cells, Cultured",
          "Cyclopentanes/*pharmacology",
          "Drug Interactions",
          "Immunohistochemistry",
          "*Kainic Acid",
          "Male",
          "Oxazines",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, sigma/*metabolism",
          "Seizures/*chemically induced"
     ],
     "EDAT": "2001/08/08 10:00",
     "MHDA": "2001/08/24 10:01",
     "CRDT": [
          "2001/08/08 10:00"
     ],
     "PHST": [
          "2001/08/08 10:00 [pubmed]",
          "2001/08/24 10:01 [medline]",
          "2001/08/08 10:00 [entrez]"
     ],
     "AID": [
          "S002432050101181X [pii]"
     ],
     "PST": "ppublish",
     "SO": "Life Sci. 2001 Jul 13;69(8):915-22.",
     "term": "hippocampus"
}